Burning Rock Biotech director reports share holdings

Burning Rock Biotech Ltd director Xu Licen Lisa filed an initial Form 3 reporting her ownership in the company.

Rhea-AI Filing Summary

Burning Rock Biotech Ltd director Xu Licen Lisa filed an initial Form 3 reporting her ownership in the company. The filing shows she directly holds 22,718 Ordinary Shares following the reported position. This is a disclosure of existing holdings and does not reflect any recent share purchase or sale activity.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Xu Licen Lisa

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 22,718 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Burning Rock Biotech (BNR) director Xu Licen Lisa’s Form 3 report?

Xu Licen Lisa’s Form 3 reports her existing ownership in Burning Rock Biotech. The filing discloses her status as a director and records her current direct holdings in the company’s Ordinary Shares, serving as an initial beneficial ownership statement rather than a transaction report.

How many Burning Rock Biotech (BNR) shares does Xu Licen Lisa report on Form 3?

Xu Licen Lisa reports holding 22,718 Ordinary Shares of Burning Rock Biotech. This figure represents her direct ownership following the reported position on the Form 3 and provides a baseline view of her stake as a company director.

Does Xu Licen Lisa’s Form 3 for Burning Rock Biotech (BNR) show any recent buy or sell transactions?

The Form 3 does not show any recent buy or sell transactions. It records a holding entry only, with 22,718 Ordinary Shares reported as owned directly, indicating disclosure of an existing position rather than new market activity.

What type of security is reported on Xu Licen Lisa’s Burning Rock Biotech (BNR) Form 3?

The Form 3 reports holdings of Ordinary Shares of Burning Rock Biotech. These Ordinary Shares represent her direct equity ownership as a director and are disclosed as part of her initial beneficial ownership statement to the market.

Is Xu Licen Lisa’s ownership in Burning Rock Biotech (BNR) direct or indirect?

The Form 3 shows Xu Licen Lisa’s ownership as direct. The filing classifies the 22,718 Ordinary Shares under direct ownership, meaning the shares are held in her own name rather than through an intermediary entity or account.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 09:45 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Xu Licen Lisa

(Last) (First) (Middle)

3463 ASHTON COURT

(Street)

PALO ALTO CA 94306

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/17/2026

3. Issuer Name and Ticker or Trading Symbol
Burning Rock Biotech Ltd [ BNR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	22,718	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 (Power of Attorney)

	/s/ Yuheng Huang, Attorney-in-Fact for Xu Licen	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.